Shareholder Capital Delivers Letter to Independent Members of the Board of Vanda Pharmaceuticals
25. April 2024 08:05 ET
|
Shareholder Capital LLC
Shareholder Capital Delivers Letter to Independent Members of the Board of Vanda Pharmaceuticals
Notice of Settlement of Derivative Suit
23. Juli 2021 15:26 ET
|
Bragar Eagel & Squire
NEW YORK, July 23, 2021 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire P.C. announces the proposed settlement of the derivative action captioned In re Vanda Pharmaceuticals Inc. Derivative...
FRIDAY DEADLINE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Vanda Pharmaceuticals Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
25. April 2019 10:00 ET
|
Schall Law
LOS ANGELES, April 25, 2019 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Vanda Pharmaceuticals Inc....
A Securities Class Action Has Been Filed Against Vanda; Block & Leviton LLP Encourages Shareholders to Contact the Firm
17. April 2019 16:11 ET
|
Block & Leviton LLP
BOSTON, April 17, 2019 (GLOBE NEWSWIRE) -- Block & Leviton LLP (www.blockesq.com), a securities litigation firm representing investors nationwide, informs investors that there has been a class...
VNDA DEADLINE: Zhang Investor Law Reminds of Deadline in Class Action Against Vanda Pharmaceuticals Inc. – VNDA
26. März 2019 14:58 ET
|
Zhang Investor Law P.C.
NEW YORK, March 26, 2019 (GLOBE NEWSWIRE) -- Zhang Investor Law announces the filing of a class action lawsuit on behalf of shareholders who bought shares of Vanda Pharmaceuticals Inc. (NASDAQ:...
SHAREHOLDER ALERT: Pawar Law Group Announces a Securities Class Action Lawsuit Against Vanda Pharmaceuticals Inc. – VNDA
20. März 2019 20:47 ET
|
Pawar Law Group
NEW YORK, March 20, 2019 (GLOBE NEWSWIRE) -- Pawar Law Group announces that a class action lawsuit has been filed on behalf of shareholders who purchased shares of Vanda Pharmaceuticals Inc....
VNDA ALERT: Zhang Investor Law Announces the Filing of a Securities Class Action Lawsuit Against Vanda Pharmaceuticals Inc. – VNDA
12. März 2019 16:44 ET
|
Zhang Investor Law P.C.
NEW YORK, March 12, 2019 (GLOBE NEWSWIRE) -- Zhang Investor Law announces the filing of a class action lawsuit on behalf of shareholders who bought shares of Vanda Pharmaceuticals Inc. (NASDAQ:...
IMPORTANT INVESTOR NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Vanda Pharmaceuticals Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
05. März 2019 14:52 ET
|
Schall Law
LOS ANGELES, March 05, 2019 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Vanda Pharmaceuticals Inc....
ONGOING INVESTIGATION: The Schall Law Firm Announces it is Investigating Claims Against Vanda Pharmaceuticals Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
14. Februar 2019 15:00 ET
|
Schall Law
LOS ANGELES, Feb. 14, 2019 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Vanda...
Vanda Pharmaceuticals Inc. Investigated by Block & Leviton LLP For Violations of Federal Securities Laws
11. Februar 2019 10:49 ET
|
Block & Leviton LLP
BOSTON, Feb. 11, 2019 (GLOBE NEWSWIRE) -- Block & Leviton LLP (www.blockesq.com), a securities litigation firm representing investors nationwide, is investigating whether Vanda Pharmaceuticals...